US 12409213
Live attenuated oral vaccine against shigellosis and typhoid fever
granted A61KA61K2039/522A61K2039/523
Quick answer
US patent 12409213 (Live attenuated oral vaccine against shigellosis and typhoid fever) held by Sanaria Inc. expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sanaria Inc.
- Grant date
- Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/522, A61K2039/523, A61K2039/543, A61K2039/70